Yabao Pharmaceutical Group Co Ltd600351
▲ PositiveCapitalrelevance
Yabao Pharmaceutical executed its first share buyback of 200,000 shares for 1.32 million yuan, a capital-return event.

Yabao Pharmaceutical announced on September 11 that the company repurchased 200,000 shares for the first time, accounting for 0.03% of total share capital, with a repurchase amount of 1.32 million yuan and a repurchase price range of 6.58 yuan to 6.59 yuan per share. In the first half of 2026, Yabao Pharmaceutical achieved revenue of 1.145 billion yuan and net profit attributable to the parent company of 178 million yuan.
Yabao Pharmaceutical Group Co LtdYabao Pharmaceutical executed its first share buyback of 200,000 shares for 1.32 million yuan, a capital-return event.